A drug that is similar to thalidomide, and is used to treat multiple myeloma and certain types of anemia. It is also used to treat mantle cell lymphoma that has come back or has not gotten better after other treatment. It is being studied in the treatment of other conditions and types of cancer. Lenalidomide may help the immune system kill abnormal blood cells or cancer cells. It may also prevent the growth of new blood vessels that tumors need to grow. It is a type of antiangiogenesis agent and a type of immunomodulating agent. Also called CC-5013 and Revlimid.
Last updated: 2016-01-06
Source: The National Cancer Institute's Dictionary of Cancer Terms (http://www.cancer.gov/dictionary)